Partnerships & OEM Leverage Advaite's existing partner network and diagnostics hub to accelerate commercialization of RapCov and other point-of-care assays through OEM, licensing, and distribution deals, tapping into hospital systems and large-scale distribution channels.

Lab Services Expansion Position the Chicago CLIA laboratory and Malvern R&D facilities as a contract development and testing hub for diagnostics and therapeutics, offering assay development, validation, and scale-up services to biotech and pharma partners.

Academic IP Licensing Explore collaborations around university IP such as the GWU HDAC6 inhibitor portfolio to co-develop or out-license therapeutics, appealing to pharma partners seeking early-stage oncology assets.

Global Collaboration Network Capitalize on international partnerships like BGI Americas and the dxpartnerships ecosystem to access global licensing, OEM, and distribution opportunities, expanding reach beyond the US.

Agile Platform Advantage Highlight a lean, cloud-enabled tech stack and agile operations to offer rapid diagnostics development, data management, and regulatory support, appealing to mid-market biotechs and larger partners seeking fast time-to-market.